Director exercised or converted 173K ROIV derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 19, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 22, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001140361-26-034066
Filed / recordedAug 22, 2026, 5:00 AM UTCAdded to OQROOct 6, 2026, 8:46 PM UTC Data qualityVerified: identifiers matched exactly IssuerRoivant Sciences Ltd. Reporting personMayukh Sukhatme RelationshipDirector, Officer Officer titlePresident & CIO TableNon-derivative (Table I) Transaction dateAug 19, 2026 Acquired / disposedAcquired (A) Shares owned after18,803,638 Around the same time
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.